Frontmatter

Articles in the same Issue

1. Frontmatter
2. Editorial
3. High-sensitivity assays for cardiac troponins
4. Reviews
5. High sensitivity cardiac troponin assays in the clinical laboratories
6. Laboratory medicine as the science that underpins medicine: the “high-sensitivity” troponin paradigm
7. Cardiac troponin assays: a review of quantitative point-of-care devices and their efficacy in the diagnosis of myocardial infarction
8. Cardiovascular Diseases
9. Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project
10. Estimation of age- and comorbidities-adjusted percentiles of high-sensitivity cardiac troponin T levels in the elderly
11. High-sensitivity cardiac troponin I in the general population – defining reference populations for the determination of the 99th percentile in the Gutenberg Health Study
12. Kinetics of high-sensitivity cardiac troponin T or troponin I compared to creatine kinase in patients with revascularized acute myocardial infarction
13. Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice
14. Diagnosis of acute myocardial infarction in patients with renal insufficiency using high-sensitivity troponin T
15. General Clinical Chemistry and Laboratory Medicine
16. Active intervention in hospital test request panels pays
17. An approach to establish the uncertainty budget of catalytic activity concentration measurements in a reference laboratory
18. Uric acid: a potential biomarker of multiple sclerosis and of its disability
19. Experience with the first fully automated chemiluminescence immunoassay for the quantification of 1α, 25-dihydroxy-vitamin D
20. I-FABP and L-FABP are early markers for abdominal injury with limited prognostic value for secondary organ failures in the post-traumatic course
21. Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation
22. Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration is not related to kidney function in elderly subjects
23. Diagnostic performance study of an antigen microarray for the detection of antiphospholipid antibodies in human serum
24. Dry ice exposure of plasma samples influences pH and lupus anticoagulant analysis
25. Reference Values and Biological Variations
26. A new robust statistical model for interpretation of differences in serial test results from an individual
27. Cancer Diagnostics
28. The value of red blood cell distribution width in endometrial cancer
29. Letters to the Editors
30. Serum high-sensitivity troponin concentrations in a multi-ethnic Asian population of stable chronic kidney disease patients
31. Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform
32. Reply to the article entitled “Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D” by Farrell et al., Clin Chem Lab Med 2014;52:1579–87
33. Reply. Impact of assay design on test performance: lessons learned from 25-hydroxyvitamin D. Authors’ response to the Letter to the Editor by Donnelly et al.
34. Therapeutic drug monitoring of voriconazole: validation of a novel ARK™ immunoassay and comparison with ultra-high performance liquid chromatography
35. Interference of C-reactive protein with clotting times